Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 5
1987 1
1989 3
1990 2
1991 3
1992 1
1994 4
1995 6
1996 4
1997 2
1998 1
2001 1
2002 4
2003 1
2004 3
2005 6
2006 9
2007 9
2008 6
2009 10
2010 7
2011 6
2012 4
2013 10
2014 12
2015 10
2016 3
2017 1
2018 3
2019 2
2020 1
2021 5
2022 1
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
Bladder cancer.
de Braud F, Maffezzini M, Vitale V, Bruzzi P, Gatta G, Hendry WF, Sternberg CN. de Braud F, et al. Among authors: maffezzini m. Crit Rev Oncol Hematol. 2002 Jan;41(1):89-106. doi: 10.1016/s1040-8428(01)00128-7. Crit Rev Oncol Hematol. 2002. PMID: 11796234 Review.
Polyclonal expansion of functional tumor-reactive lymphocytes infiltrating glioblastoma for personalized cell therapy.
Maffezzini M, Musio S, Di Ianni N, Rumolo A, Patanè M, Galluzzo A, Sambruni I, Berlendis A, Aquino D, Baso G, Zingarelli M, Facciolla M, Maddaloni L, Valentino R, Paterra R, Agistri F, Farinotti M, Mattei L, Coluccia P, Acerbi F, DiMeco F, Pollo B, Silvani A, Eoli M, Traversari C, Montagna D, Pellegatta S. Maffezzini M, et al. Nat Commun. 2025 Aug 25;16(1):7279. doi: 10.1038/s41467-025-62263-2. Nat Commun. 2025. PMID: 40855052 Free PMC article.
Bladder cancer.
Maffezzini M, Audisio R, Pavone-Macaluso M, Hall RR. Maffezzini M, et al. Crit Rev Oncol Hematol. 1998 Feb;27(2):151-3. doi: 10.1016/s1040-8428(97)10026-9. Crit Rev Oncol Hematol. 1998. PMID: 9571320 Review. No abstract available.
The anti-aging Klotho protects glioblastoma macrophages from radiotherapy-induced inflammation and predicts immunotherapy response.
Galluzzo A, Maffezzini M, Fumagalli ML, Sambruni I, Musio S, Patanè M, Paterra R, Salvi E, Facciolla M, Milani M, Schiariti M, Mattei L, Rossi A, Eoli M, Poliani L, Silvani A, Pollo B, Fariselli L, Di Ianni N, Pellegatta S. Galluzzo A, et al. Among authors: maffezzini m. Int J Cancer. 2025 Nov 15;157(10):2156-2172. doi: 10.1002/ijc.70038. Epub 2025 Jul 21. Int J Cancer. 2025. PMID: 40686387 Free PMC article.
Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment.
de Vos II, Marenghi C, Badenchini F, Boevé ER, Lozano-Uruñuela F, Graefen M, Rannikko AS, Staerman F, Sugimoto M, Kato T, Somford DM, Frydenberg M, Bangma CH, Remmers S, Roobol MJ; Prostate Cancer Research International: Active Surveillance (PRIAS) consortium. de Vos II, et al. BJU Int. 2025 Aug;136(2):245-253. doi: 10.1111/bju.16727. Epub 2025 Apr 14. BJU Int. 2025. PMID: 40223578 Free PMC article.
Estimates of prostate cancer burden in Italy.
Capocaccia R, Foschi R, Zucchetto A, Valdagni R, Nicolai N, Maffezzini M, Gatta G. Capocaccia R, et al. Among authors: maffezzini m. Cancer Epidemiol. 2016 Feb;40:166-72. doi: 10.1016/j.canep.2015.12.004. Epub 2015 Dec 29. Cancer Epidemiol. 2016. PMID: 26771313
127 results